Literature DB >> 8199182

Resistance to insulin-stimulated glucose uptake and dyslipidemia in Asian Indians.

A Laws1, J L Jeppesen, P C Maheux, P Schaaf, Y D Chen, G M Reaven.   

Abstract

Persons from the Indian subcontinent have elevated coronary heart disease risk. We measured insulin resistance with the insulin suppression test in 22 Asian Indian men and women and an equal number of control subjects of European ancestry matched for age and body mass index. Asian men and women had increased glucose and insulin responses to oral glucose tolerance tests (P < .05 by ANOVA) and had approximately 60% higher steady-state plasma glucose levels during the insulin suppression test (P < .001 by ANOVA), consistent with insulin resistance. In response to mixed meals, Asian women had higher plasma free fatty acids and glycerol concentrations than women of European ancestry (P < .02 by ANOVA), whereas Asian Indian men had similar free fatty acid and glycerol levels compared with men of European ancestry despite higher plasma insulin levels. Thus, results in both sexes were consistent with resistance to insulin suppression of free fatty acid levels in Asian Indians. Asian Indians of both sexes had higher fasting plasma triglyceride (P < .01) and lower high-density lipoprotein cholesterol (P < .01) concentrations than men and women of European ancestry. Resistance to insulin-stimulated glucose uptake and to insulin suppression of free fatty acid levels in Asian Indians is associated with a number of metabolic abnormalities that are demonstrated risk factors for coronary heart disease, including increased glucose, insulin, and triglyceride concentrations and decreased high-density lipoprotein cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199182     DOI: 10.1161/01.atv.14.6.917

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  8 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Adiposity and cardiovascular risk clustering in South Asians.

Authors:  Elena Flowers; César Molina; Ashish Mathur; Gerald M Reaven
Journal:  Metab Syndr Relat Disord       Date:  2013-09-04       Impact factor: 1.894

3.  Fat distribution and insulin resistance in young adult nonobese Asian Indian women.

Authors:  Magdalene Szuszkiewicz-Garcia; Rong Li; Scott M Grundy; Nicola Abate; Manisha Chandalia
Journal:  Metab Syndr Relat Disord       Date:  2012-06-29       Impact factor: 1.894

4.  Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia.

Authors:  Viraj Raygor; Fahim Abbasi; Laura C Lazzeroni; Sun Kim; Erik Ingelsson; Gerald M Reaven; Joshua W Knowles
Journal:  Diab Vasc Dis Res       Date:  2019-03       Impact factor: 3.291

5.  Use of plasma triglyceride/high-density lipoprotein cholesterol ratio to identify increased cardio-metabolic risk in young, healthy South Asians.

Authors:  Elena Flowers; César Molina; Ashish Mathur; Gerald M Reaven
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

6.  Comparison of relative waist circumference between Asian Indian and US adults.

Authors:  Harpreet S Bajaj; Mark A Pereira; Rajit Mohan Anjana; Raj Deepa; Viswanathan Mohan; Noel T Mueller; Gundu H R Rao; Myron D Gross
Journal:  J Obes       Date:  2014-09-21

Review 7.  Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites.

Authors:  Elizabeth M Rhea; William A Banks; Jacob Raber
Journal:  Biomedicines       Date:  2022-07-02

8.  Ethnic- and sex-specific associations between plasma fatty acids and markers of insulin resistance in healthy young adults.

Authors:  Jessica C Ralston; Michael A Zulyniak; Daiva E Nielsen; Shannon Clarke; Alaa Badawi; Ahmed El-Sohemy; David Wl Ma; David M Mutch
Journal:  Nutr Metab (Lond)       Date:  2013-06-17       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.